{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:53:26Z","timestamp":1790780006875,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2014.131","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T09:36:28Z","timestamp":1420536988000},"page":"e492-e492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington's disease"],"prefix":"10.1038","volume":"5","author":[{"given":"D J","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Renoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z M","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A E","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P S","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D R","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S L","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L J","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,6]]},"reference":[{"key":"BFtp2014131_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971\u2013983.","journal-title":"Cell"},{"key":"BFtp2014131_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr . Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559\u2013577.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFtp2014131_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1126\/science.2931802","volume":"230","author":"RJ Ferrante","year":"1985","unstructured":"Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB . Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985; 230: 561\u2013563.","journal-title":"Science"},{"key":"BFtp2014131_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M . Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985; 227: 770\u2013773.","journal-title":"Science"},{"key":"BFtp2014131_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","volume":"9","author":"SE Browne","year":"1999","unstructured":"Browne SE, Ferrante RJ, Beal MF . Oxidative stress in Huntington's disease. Brain Pathol 1999; 9: 147\u2013163.","journal-title":"Brain Pathol"},{"key":"BFtp2014131_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997; 41: 646\u2013653.","journal-title":"Ann Neurol"},{"key":"BFtp2014131_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH . Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 1999; 45: 25\u201332.","journal-title":"Ann Neurol"},{"key":"BFtp2014131_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada Sanchez","year":"2008","unstructured":"Estrada Sanchez AM, Mejia-Toiber J, Massieu L . Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Arch Med Res 2008; 39: 265\u2013276.","journal-title":"Arch Med Res"},{"key":"BFtp2014131_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"O Dean","year":"2011","unstructured":"Dean O, Giorlando F, Berk M . N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 2011; 36: 78\u201386.","journal-title":"J Psychiatry Neurosci"},{"key":"BFtp2014131_CR10","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s00415-007-0611-y","volume":"254","author":"N Klepac","year":"2007","unstructured":"Klepac N, Relja M, Klepac R, Hecimovic S, Babic T, Trkulja V . Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study. J Neurol 2007; 254: 1676\u20131683.","journal-title":"J Neurol"},{"key":"BFtp2014131_CR11","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","volume":"79","author":"MB Bogdanov","year":"2001","unstructured":"Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF . Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J Neurochem 2001; 79: 1246\u20131249.","journal-title":"J Neurochem"},{"key":"BFtp2014131_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","volume":"6","author":"OI Aruoma","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J . The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593\u2013597.","journal-title":"Free Radic Biol Med"},{"key":"BFtp2014131_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"KR Atkuri","year":"2007","unstructured":"Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA . N-Acetylcysteine\u2014a safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol 2007; 7: 355\u2013359.","journal-title":"Curr Opin Pharmacol"},{"key":"BFtp2014131_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature13136","volume":"509","author":"BD Paul","year":"2014","unstructured":"Paul BD, Sbodio JI, Xu R, Vandiver MS, Cha JY, Snowman AM et al. Cystathionine [ggr]-lyase deficiency mediates neurodegeneration in Huntington's disease. Nature 2014; 509: 96\u2013100.","journal-title":"Nature"},{"key":"BFtp2014131_CR15","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1523\/JNEUROSCI.15-05-03775.1995","volume":"15","author":"C Portera-Cailliau","year":"1995","unstructured":"Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE . Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995; 15: 3775\u20133787.","journal-title":"J Neurosci"},{"key":"BFtp2014131_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","volume":"23","author":"C Cepeda","year":"2003","unstructured":"Cepeda C, Hurst RS, Calvert CR, Hernandez-Echeagaray E, Nguyen OK, Jocoy E et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 2003; 23: 961\u2013969.","journal-title":"J Neurosci"},{"key":"BFtp2014131_CR17","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1007\/s100720200081","volume":"23","author":"C Lucetti","year":"2002","unstructured":"Lucetti C, Gambaccini G, Bernardini S, Dell'Agnello G, Petrozzi L, Rossi G et al. Amantadine in Huntington's disease: open-label video-blinded study. Neurol Sci 2002; 23: S83\u2013S84.","journal-title":"Neurol Sci"},{"key":"BFtp2014131_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-7091-0579-5_14","volume-title":"Focus on Extrapyramidal Dysfunction","author":"A. Beister","year":"2004","unstructured":"Beister A, Kraus P, Kuhn W, Dose M, Weindl A, Gerlach M . The N-methyl-D-aspartate antagonist memantine retards progression of Huntington\u2019s disease. In: M\u00fcller T, Riederer P (eds). Focus on Extrapyramidal Dysfunction, vol. 68. Springer: Vienna, 2004, pp 117-22."},{"key":"BFtp2014131_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","volume":"8","author":"JC Lievens","year":"2001","unstructured":"Lievens JC, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L et al. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis 2001; 8: 807\u2013821.","journal-title":"Neurobiol Dis"},{"key":"BFtp2014131_CR20","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","volume":"125","author":"PF Behrens","year":"2002","unstructured":"Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB . Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002; 125: 1908\u20131922.","journal-title":"Brain"},{"key":"BFtp2014131_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1423-0127-17-62","volume":"17","author":"Y Sari","year":"2010","unstructured":"Sari Y, Prieto AL, Barton SJ, Miller BR, Rebec GV . Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6\/2 model of Huntington's disease. J Biomed Sci 2010; 17: 62.","journal-title":"J Biomed Sci"},{"key":"BFtp2014131_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0165-6147(02)02060-6","volume":"23","author":"GJ McBean","year":"2002","unstructured":"McBean GJ . Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol Sci 2002; 23: 299\u2013302.","journal-title":"Trends Pharmacol Sci"},{"key":"BFtp2014131_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.biopsych.2013.03.032","volume":"73","author":"G Sanacora","year":"2013","unstructured":"Sanacora G, Banasr M . From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 2013; 73: 1172\u20131179.","journal-title":"Biol Psychiatry"},{"key":"BFtp2014131_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/bst0290717","volume":"29","author":"GJ McBean","year":"2001","unstructured":"McBean GJ, Flynn J . Molecular mechanisms of cystine transport. Biochem Soc Trans 2001; 29: 717\u2013722.","journal-title":"Biochem Soc Trans"},{"key":"BFtp2014131_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0197-0186(00)00035-8","volume":"37","author":"AS Bender","year":"2000","unstructured":"Bender AS, Reichelt W, Norenberg MD . Characterization of cystine uptake in cultured astrocytes. Neurochem Int 2000; 37: 269\u2013276.","journal-title":"Neurochem Int"},{"key":"BFtp2014131_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nn.2250","volume":"12","author":"K Moussawi","year":"2009","unstructured":"Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A et al. N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 2009; 12: 182\u2013189.","journal-title":"Nat Neurosci"},{"key":"BFtp2014131_CR27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.biopsych.2011.10.024","volume":"71","author":"YM Kupchik","year":"2012","unstructured":"Kupchik YM, Moussawi K, Tang X-C, Wang X, Kalivas BC, Kolokithas R et al. The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry 2012; 71: 978\u2013986.","journal-title":"Biol Psychiatry"},{"key":"BFtp2014131_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493\u2013506.","journal-title":"Cell"},{"key":"BFtp2014131_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2202-9-34","volume":"9","author":"A van Dellen","year":"2008","unstructured":"van Dellen A, Cordery PM, Spires TL, Blakemore C, Hannan AJ . Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease. BMC Neurosci 2008; 9: 34.","journal-title":"BMC Neurosci"},{"key":"BFtp2014131_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","volume":"153","author":"BR Miller","year":"2008","unstructured":"Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR et al. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse. Neuroscience 2008; 153: 329\u2013337.","journal-title":"Neuroscience"},{"key":"BFtp2014131_CR31","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/ejn.12202","volume":"38","author":"GT Petr","year":"2013","unstructured":"Petr GT, Schultheis LA, Hussey KC, Sun Y, Dubinsky JM, Aoki C et al. Decreased expression of GLT-1 in the R6\/2 model of Huntington's disease does not worsen disease progression. Eur J Neurosci 2013; 38: 2477\u20132490.","journal-title":"Eur J Neurosci"},{"key":"BFtp2014131_CR32","doi-asserted-by":"publisher","first-page":"e22133","DOI":"10.1371\/journal.pone.0022133","volume":"6","author":"T Renoir","year":"2011","unstructured":"Renoir T, Zajac MS, Du X, Pang T, Leang L, Chevarin C et al. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington\u2019s disease and depression. PLoS One 2011; 6: e22133.","journal-title":"PLoS One"},{"key":"BFtp2014131_CR33","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1039\/C4AN00255E","volume":"139","author":"ZM Smith","year":"2014","unstructured":"Smith ZM, Terry JM, Barnett NW, Gray LJ, Wright DJ, Francis PS . Enhancing permanganate chemiluminescence detection for the determination of glutathione and glutathione disulfide in biological matrices. Analyst 2014; 139: 2416\u20132422.","journal-title":"Analyst"},{"key":"BFtp2014131_CR34","doi-asserted-by":"publisher","first-page":"e21746","DOI":"10.1371\/journal.pone.0021746","volume":"6","author":"GW Rogers","year":"2011","unstructured":"Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, Ferrick DA et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One 2011; 6: e21746.","journal-title":"PLoS One"},{"key":"BFtp2014131_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000331724","volume":"28","author":"SL McGee","year":"2011","unstructured":"McGee SL, Sadli N, Morrison S, Swinton C, Suphioglu C . DHA protects against zinc mediated alterations in neuronal cellular bioenergetics. Cell Physiol Biochem 2011; 28: 157\u2013162.","journal-title":"Cell Physiol Biochem"},{"key":"BFtp2014131_CR36","first-page":"308","volume":"311","author":"S Bannai","year":"1984","unstructured":"Bannai S, Christensen HN, Vadgama JV, Ellory JC, Englesberg E, Guidotti GG et al. Amino acid transport systems. Nature 1984; 311: 308.","journal-title":"Nature"},{"key":"BFtp2014131_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","volume":"329","author":"I Dalle-Donne","year":"2003","unstructured":"Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R . Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003; 329: 23\u201338.","journal-title":"Clin Chim Acta"},{"key":"BFtp2014131_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1017\/S109285290002201X","volume":"6","author":"JR Slaughter","year":"2001","unstructured":"Slaughter JR, Martens MP, Slaughter KA . Depression and Huntington's disease: prevalence, clinical manifestations, etiology, and treatment. CNS Spectr 2001; 6: 306\u2013326.","journal-title":"CNS Spectr"},{"key":"BFtp2014131_CR39","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999; 19: 3248\u20133257.","journal-title":"J Neurosci"},{"key":"BFtp2014131_CR40","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/hmg\/ddq253","volume":"19","author":"BR Underwood","year":"2010","unstructured":"Underwood BR, Imarisio S, Fleming A, Rose C, Krishna G, Heard P et al. Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Hum Mol Genet 2010; 19: 3413\u20133429.","journal-title":"Hum Mol Genet"},{"key":"BFtp2014131_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.immuni.2013.07.017","volume":"39","author":"YT Ma","year":"2013","unstructured":"Ma YT, Galluzzi L, Zitvogel L, Kroemer G . Autophagy and cellular immune responses. Immunity 2013; 39: 211\u2013227.","journal-title":"Immunity"},{"key":"BFtp2014131_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nbd.2014.05.004","volume":"69","author":"C Mo","year":"2014","unstructured":"Mo C, Pang TY, Ransome MI, Hill RA, Renoir T, Hannan AJ . High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice. Neurobiol Dis 2014; 69: 248\u2013262.","journal-title":"Neurobiol Dis"},{"key":"BFtp2014131_CR43","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1093\/hmg\/ddt667","volume":"23","author":"M Maheshwari","year":"2014","unstructured":"Maheshwari M, Bhutani S, Das A, Mukherjee R, Sharma A, Kino Y et al. Dexamethasone induces heat shock response and slows down disease progression in mouse and fly models of Huntingtons disease. Hum Mol Genet 2014; 23: 2737\u20132751.","journal-title":"Hum Mol Genet"},{"key":"BFtp2014131_CR44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.brainresbull.2008.10.007","volume":"78","author":"PN Pallier","year":"2009","unstructured":"Pallier PN, Drew CJG, Morton AJ . The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res Bull 2009; 78: 347\u2013355.","journal-title":"Brain Res Bull"},{"key":"BFtp2014131_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fneur.2013.00081","volume":"4","author":"X Du","year":"2013","unstructured":"Du X, Pang TYC, Hannan AJ . A tale of two maladies? Pathogenesis of depression with and without the Huntington's disease gene mutation. Front Neurol 2013; 4: 81.","journal-title":"Front Neurol"},{"key":"BFtp2014131_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-61779-458-2_7","volume":"829","author":"DH Overstreet","year":"2012","unstructured":"Overstreet DH . Modeling depression in animal models. Methods Mol Biol 2012; 829: 125\u2013144.","journal-title":"Methods Mol Biol"},{"key":"BFtp2014131_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I et al. N-acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial. Biol Psychiatry 2008; 64: 468\u2013475.","journal-title":"Biol Psychiatry"},{"key":"BFtp2014131_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH . Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996; 39: 385\u2013389.","journal-title":"Ann Neurol"},{"key":"BFtp2014131_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1749-6632.1999.tb07827.x","volume":"893","author":"T Grunewald","year":"1999","unstructured":"Grunewald T, Beal MF . Bioenergetics in Huntington's disease. Ann N Y Acad Sci 1999; 893: 203\u2013213.","journal-title":"Ann N Y Acad Sci"},{"key":"BFtp2014131_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","volume":"47","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G et al. Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse. Ann Neurol 2000; 47: 80\u201386.","journal-title":"Ann Neurol"},{"key":"BFtp2014131_CR51","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum Mol Genet 2010; 19: 3053\u20133067.","journal-title":"Hum Mol Genet"},{"key":"BFtp2014131_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","volume":"34","author":"AM Estrada-Sanchez","year":"2009","unstructured":"Estrada-Sanchez AM, Montiel T, Segovia J, Massieu L . Glutamate toxicity in the striatum of the R6\/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol Dis 2009; 34: 78\u201386.","journal-title":"Neurobiol Dis"},{"key":"BFtp2014131_CR53","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW et al. The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 2013; 18: 522\u2013555.","journal-title":"Antioxid Redox Signal"},{"key":"BFtp2014131_CR54","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","volume":"65","author":"LA Knackstedt","year":"2009","unstructured":"Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S et al. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry 2009; 65: 841\u2013845.","journal-title":"Biol Psychiatry"},{"key":"BFtp2014131_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/BC.2003.059","volume":"384","author":"R Dringen","year":"2003","unstructured":"Dringen R, Hirrlinger J . Glutathione pathways in the brain. Biol Chem 2003; 384: 505\u2013516.","journal-title":"Biol Chem"},{"key":"BFtp2014131_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","volume":"34","author":"M Berk","year":"2013","unstructured":"Berk M, Malhi GS, Gray LJ, Dean OM . The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 2013; 34: 167\u2013177.","journal-title":"Trends Pharmacol Sci"},{"key":"BFtp2014131_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1471-4159.2004.02851.x","volume":"92","author":"O Garcia","year":"2005","unstructured":"Garcia O, Almeida A, Massieu L, Bolanos JP . Increased mitochondrial respiration maintains the mitochondrial membrane potential and promotes survival of cerebellar neurons in an endogenous model of glutamate receptor activation. J Neurochem 2005; 92: 183\u2013190.","journal-title":"J Neurochem"},{"key":"BFtp2014131_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1471-4159.2009.05936.x","volume":"109","author":"AL Wadey","year":"2009","unstructured":"Wadey AL, Muyderman H, Kwek PT, Sims NR . Mitochondrial glutathione uptake: characterization in isolated brain mitochondria and astrocytes in culture. J Neurochem 2009; 109: 101\u2013108.","journal-title":"J Neurochem"},{"key":"BFtp2014131_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1471-4159.1981.tb01608.x","volume":"36","author":"TL Perry","year":"1981","unstructured":"Perry TL, Hansen S, Gandham SS . Postmortem changes of amino compounds in human and rat brain. J Neurochem 1981; 36: 406\u2013410.","journal-title":"J Neurochem"},{"key":"BFtp2014131_CR60","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.freeradbiomed.2012.06.008","volume":"53","author":"A Siddiqui","year":"2012","unstructured":"Siddiqui A, Rivera-Sanchez S, Castro MDR, Acevedo-Torres K, Rane A, Torres-Ramos CA et al. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease. Free Radic Biol Med 2012; 53: 1478\u20131488.","journal-title":"Free Radic Biol Med"},{"key":"BFtp2014131_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"552","author":"JF Turrens","year":"2003","unstructured":"Turrens JF . Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552: 335\u2013344.","journal-title":"J Physiol"},{"key":"BFtp2014131_CR62","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"WA Brennan Jr","year":"1985","unstructured":"Brennan WA Jr ., Bird ED, Aprille JR . Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985; 44: 1948\u20131950.","journal-title":"J Neurochem"},{"key":"BFtp2014131_CR63","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","volume":"17","author":"A Benchoua","year":"2006","unstructured":"Benchoua A, Trioulier Y, Zala D, Gaillard M-C, Lefort N, Dufour N et al. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 2006; 17: 1652\u20131663.","journal-title":"Mol Biol Cell"},{"key":"BFtp2014131_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","volume":"67","author":"J Butterworth","year":"1985","unstructured":"Butterworth J, Yates CM, Reynolds GP . Distribution of phosphate- activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase andgamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases. J Neurol Sci 1985; 67: 161\u2013171.","journal-title":"J Neurol Sci"},{"key":"BFtp2014131_CR65","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000321681","volume":"8","author":"SF Zhang","year":"2011","unstructured":"Zhang SF, Hennessey T, Yang L, Starkova NN, Beal MF, Starkov AA . Impaired brain creatine kinase activity in Huntington's disease. Neurodegener Dis 2011; 8: 194\u2013201.","journal-title":"Neurodegener Dis"},{"key":"BFtp2014131_CR66","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","volume":"287","author":"F Mochel","year":"2012","unstructured":"Mochel F, Durant B, Meng X, O'Callaghan J, Yu H, Brouillet E et al. Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem 2012; 287: 1361\u20131370.","journal-title":"J Biol Chem"},{"key":"BFtp2014131_CR67","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4614-3573-0_6","volume":"748","author":"S Drose","year":"2012","unstructured":"Drose S, Brandt U . Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol 2012; 748: 145\u2013169.","journal-title":"Adv Exp Med Biol"},{"key":"BFtp2014131_CR68","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.biopsych.2012.04.001","volume":"71","author":"OM Dean","year":"2012","unstructured":"Dean OM, Bush AI, Berk M . Translating the Rosetta Stone of N-acetylcysteine. Biol Psychiatry 2012; 71: 935\u2013936.","journal-title":"Biol Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2014131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2014131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2014131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:09:08Z","timestamp":1672895348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2014131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,6]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1]]}},"alternative-id":["BFtp2014131"],"URL":"https:\/\/doi.org\/10.1038\/tp.2014.131","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,6]]},"assertion":[{"value":"10 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}